Senescence

Longevity investment: Apollo aims for the moon

Co-founder of Longevity-focused investment firm shows you can target aging AND appeal to biotech investors. Founded in 2016, Berlin and Boston-based Apollo already boasts an...

Cosmetic therapeutic senolytics: aging isn’t just skin-deep

When is a cosmetic product also a therapy? When it's a patented senolytic that tackles aging at a cellular level. OneSkin began life validating how...

Leading academic “profoundly disappointed” by COVID-19 response

Professor Richard Faragher asks why developments in aging research have been largely ignored in the global response to the COVID-19 pandemic. With the world currently...

Geroscience – Longevity and the COVID-19 upside

New paper examines using a geroscience approach, both in terms of fighting COVID-19 and towards a wider Longevity framework. Geroscience is all about understanding the...

Exclusive interview: Professor Richard Faragher and cellular senescence

With senolytics driving investor interest in the Longevity sector, we speak to Professor Richard Faragher about resveratrol and the potential for rejuvenation of senescent...

Re-engineered immune cells are the life and soul of the CAR T

Chimeric cells prove effective senolytic agents in targeting aging. CAR T cells are being deployed against diseases caused by senescence with the hope that they...

Protein’s ability to slow cell growth is Longevity boost

UCL, UEL and Essex University collaboration has discovered that the protein Gaf1 plays a key role in determining the lifespan of cells. A research team...

Link between cellular senescence and plaque formation found

Study identifies CD9 as a novel target to prevent senescence and treat vascular aging. CD9 is a protein expressed on the surface of various cell types,...

Video interview: talking senescence with Nina Khera

Teenage founder of Canadian start-up Biotein hunts a universal phenotype for senescent cells. As we’ve covered in the past, Biotein’s Nina Khera has a mission...

“Avoid the use of DQ as a senolytic therapy”

Forever Healthy Foundation issues risk-benefit analysis on dasatinib + quercetin as a senolytic. The Forever Healthy Foundation today published its latest risk-benefit analysis, which explores...

New benchmark for senescence developed from CellAge database

Comprehensive cellular senescence database will provide benchmark for the development of senolytic therapies. Our cells are intrinsically programmed for senescence – a gradual aging and...

Biomarkers for aging – a consensus is needed now more than ever

Slowing, stopping and even reversing aging – how can we research progress if we can't measure success? Biomarkers of aging are pretty important in the...

Longevity Leaders World Congress goes virtual

Annual Longevity conference gets a digital makeover as the community adapts to COVID-19. With much of the world still in some form of lockdown, the...

Making the Longevity grade: expanded list of 1000 leading names

2020 list showcases a growing network of Longevity influencers from the worlds of aging research, technology, policy, media and investment. Who's who in Longevity? Following-on...

Jim Mellon donates £1 million to Oriel for aging research

Oxford University's Longevity science given a £1 million boost by donation. Oriel College, Oxford, is a focal point for the efforts to improve future health...

Telomeres – it’s not the end of the line

Sigh of relief as new study identifies possible drug treatments for telomere diseases – are we finally edging closing to unlocking the potential of...

Classifying aging as a disease – it’s all about the ‘how’

The hurdle of classifying aging as a disease, rather than an inevitability, has started to be overcome. Now Alex Zhavoronkov is pushing for us...

Longevity and the art of motorcycle maintenance

OpenCures' Kevin Perrott talks about empowering the consumer with their own health data. One of the Longevity sector’s leading voices came to the field relatively...

Longevity2020: Day 5 Recap

On Friday, the Longevity2020 online conference drew to a close, and the final day explored what people can be doing today to address their...

Longevity2020: Day 2 recap

Yesterday at Longevity2020 was all about rejuvenation therapies, bringing together some of the world’s leading luminaries in the fight against aging. Things kicked off with...

Latest articles

Evidence for tenth hallmark of aging increases with new paper

Is ten the new nine? Additional research adds weight to the argument that extracellular matrix stiffening should be considered the tenth hallmark of aging. Since...

Help us help you: Longevity biotech survey

A new survey on translational processes and hurdles to clinical trials in Longevity biotech. We're working with two MDs: Oliver Zolman and Jian Fransen, on...

First Longevity announces first investors for current round

Some news of our own: European VC fund and a Longevity innovator participate in the First Longevity funding round. Last week we announced that Tom...

GDF15 protects from age‐related metabolic phenotypes

A recent study shows an important role for GDF15 in preventing aging-induced metabolic phenotypes by modulating systemic inflammatory responses in humans and mice. Dysfunction of...